Metropolitan Life Insurance CO Praxis Precision Medicines, Inc. Transaction History

Metropolitan Life Insurance CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.75 - $11.34 $4,275 - $27,703	-2,443 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$10.21 - $20.29 $24,943 - $49,568	2,443 New	2,443 $24,000
Q1 2022 Mar 30, 2023	SELL	$10.21 - $20.29 $64,731 - $128,638	-6,340 Reduced 72.18%	2,443 $24,000
Q1 2022 May 12, 2022	SELL	$10.21 - $20.29 $64,731 - $128,638	-6,340 Reduced 72.18%	2,443 $25,000
Q4 2021 Jun 21, 2023	BUY	$16.76 - $22.99 $147,203 - $201,921	8,783 New	8,783 $173,000

Q4 2021 Mar 30, 2023	BUY	$16.76 - $22.99 $8,128 - $11,150	485 Added 5.84%	8,783 $173,000
Q4 2021 Feb 15, 2022	BUY	$16.76 - $22.99 $8,128 - $11,150	485 Added 5.84%	8,783 $173,000
Q3 2021 Jun 21, 2023	BUY	$13.15 - $22.56 $109,118 - $187,202	8,298 New	8,298 $153,000
Q2 2021 Mar 30, 2023	BUY	$18.28 - $33.05 $85,312 - $154,244	4,667 Added 128.53%	8,298 $151,000
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $151,614 - $274,116	8,294 Added 207350.0%	8,298 $152,000
Q1 2021 Jun 26, 2023	BUY	$29.34 - $60.2 $106,533 - $218,586	3,631 New	3,631 $119 Million
Q1 2021 May 14, 2021	SELL	$29.34 - $60.2 $106,416 - $218,345	-3,627 Reduced 99.89%	4 $119,000
Q4 2020 Jun 22, 2023	BUY	$27.25 - $55.82 $98,944 - $202,682	3,631 New	3,631 $199,000
Q4 2020 Mar 30, 2023	BUY	$27.25 - $55.82 $98,944 - $202,682	3,631 New	3,631 $199,000
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $98,944 - $202,682	3,631 New	3,631 $200,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.